DelveInsight’s “Pancreatic Cancer - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Pancreatic Cancer for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Pancreatic Cancer from 2010-2020.Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. The most common, pancreatic adenocarcinoma, accounts for about 85% of cases. Those cases not treatable with surgery have an average five-year survival rate of 16%.Globally pancreatic cancer is the 11th most common cancer in women and the 12th most common in men. Efforts are underway to develop new drugs. Some of these involve targeted therapies against the cancer cells' molecular mechanisms. Others aim to target the highly resistant cancer stem cells. A further approach involves the use of immunotherapy, such as oncolytic viruses.
Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
It also provides Market size of Pancreatic Cancer for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
Note*: This report requires 5-10 business days to complete.